The US giant Johnson & Johnson’s attempt to prolong its patent on the life-saving TB drug Bedaquiline was rejected by the Indian Patent Office (IPO), a decision that will help tuberculosis patients. This decision may make it easier for millions of patients in India and throughout the world to obtain more affordable versions of the … Continue reading J&J Denied Patent Extension on TB Drug Bedaquiline, Boosting Patient Access